Inhibition of Human Breast Cancer Cell Invasion by siRNA Against Urokinase-Type Plasminogen Activator

被引:33
作者
Huang, Hong-Yan [2 ,3 ]
Jiang, Ze-Fei [3 ]
Li, Qing-Xia [2 ]
Liu, Jia-Yun [1 ]
Wang, Tao [3 ]
Zhang, Rui [2 ]
Zhao, Jing [2 ]
Xu, Yan-Ming [2 ]
Bao, Wei [1 ]
Zhang, Yong [1 ]
Jia, Lin-Tao [2 ]
Yang, An-Gang [1 ,2 ]
机构
[1] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Shaanxi Prov, Peoples R China
[2] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Shaanxi Prov, Peoples R China
[3] Acad Mil Med Sci, Affiliated Hosp, Dept Breast Canc, Beijing, Peoples R China
基金
国家高技术研究发展计划(863计划); 中国国家自然科学基金;
关键词
Urokinase plasminogen activator; Breast cancer; Metastasis; TUMOR-GROWTH; FIBRIN ZYMOGRAPHY; STABLE KNOCKDOWN; GENE-EXPRESSION; DOWN-REGULATION; ANTISENSE UPAR; RECEPTOR; ANGIOGENESIS; METASTASIS; RNAI;
D O I
10.3109/07357901003735642
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Urokinase plasminogen activator (uPA) correlates closely with breast cancer metastasis via triggering the degradation of divergent matrix proteins. Here, uPA was selectively knocked down in breast carcinoma MDA-MB-231 cells by siRNAs. The in vitro migration of MDA-MB-231 cells was effectively suppressed accompanied by a decrease in extracellular MMP-9 activities. The colony formation ability of MDA-MB-231 cells was inhibited following uPA knockdown, while the proliferation was not affected. The uPA knockdown in MDA-MB-231 cells caused significantly suppressed tumor metastasis in nude mice. Thus, siRNAs targeted to uPA have implications in the development of novel approaches to preventing breast cancer metastasis.
引用
收藏
页码:689 / 697
页数:9
相关论文
共 39 条
[1]
RETRACTED: Down-Regulation of uPA and uPAR by 3,3′-Diindolylmethane Contributes to the Inhibition of Cell Growth and Migration of Breast Cancer Cells (Retracted article. See vol. 117, pg. 1959, 2016) [J].
Ahmad, Aamir ;
Kong, Dejuan ;
Wang, Zhiwei ;
Sarkar, Sanila. H. ;
Banerjee, Sanjeev ;
Sarkar, Fazlul H. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (04) :916-925
[2]
Arens N, 2005, INT J ONCOL, V26, P113
[3]
Evolving role of uPA/uPAR system in human cancers [J].
Ass, Kathleen ;
Ahmad, Aamir ;
Azmi, Asfar S. ;
Sarkar, Sarah H. ;
Sarkar, Fazlul H. .
CANCER TREATMENT REVIEWS, 2008, 34 (02) :122-136
[4]
uPAR: A versatile signalling orchestrator [J].
Blasi, F ;
Carmeliet, P .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :932-943
[5]
Structure and function of the plasminogen/plasmin system [J].
Castellino, FJ ;
Ploplis, VA .
THROMBOSIS AND HAEMOSTASIS, 2005, 93 (04) :647-654
[6]
Two fibrin zymography methods for analysis of plasminogen activators on gels [J].
Choi, NS ;
Kim, SH .
ANALYTICAL BIOCHEMISTRY, 2000, 281 (02) :236-238
[7]
Cancer invasion and metastasis: changing views [J].
Duffy, M. J. ;
McGowan, P. M. ;
Gallagher, W. M. .
JOURNAL OF PATHOLOGY, 2008, 214 (03) :283-293
[8]
The urokinase plasminogen activator system: Role in malignancy [J].
Duffy, MJ .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (01) :39-49
[9]
Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO
[10]
2-9